Our research reveals a decrease in the levels of PDCD10 (logFC: −3.717, p.value: 6.65E‐16) in cisplatin‐resistant NSCLC cells compared to those that are sensitive, highlighting the need for additional experimental investigations for a more thorough comprehension. This evidence concerns the gene PDCD10 and non-small cell lung carcinoma.